Atorvastatin
Effect of Rosuvastatin Versus Placebo on Cardiovascular Outcomes in Patients with End-Stage Renal Disease on Hemodialysis – Results of the AURORA Study.
Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes.
Atherogenic Diabetic Dyslipidemia (ADD) - Time to Relook & Evaluate Treatment Options.
Dr François Diévart Clinique Villette Dunkerque Place des statines dans la prise en charge du patient à haut risque cardiovasculaire.
Antiaggregazione nel diabetico: Credenze ed evidenze Department of Clinical Pharmacology and Epidemiology Consorzio Mario Negri Sud S. Maria Imbaro (CH)
Dai grandi trials con statine al razionale del target terapeutico del colesterolo in prevenzione secondaria Angelo Pucci Cardiologia-UTIC Carrara AUSL1-
Inflammation Persists Even During HIV Therapy
AHA 2012 Research Highlights
14.09 bp management in diabetes
The Western Norway B Vitamin Intervention Trial (Wenbi Tb
Dr Mark Latt, Geriatrician, Royal Prince Alfred Hospital & Senior Lecturer, Sydney Medical School, The University of Sydney - A Clinician’s Perspective: Hypothetical Scenarios in
